Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.

@article{Golomb2007PotentialLB,
  title={Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.},
  author={Beatrice A. Golomb and Marcella A. Evans},
  journal={The Medical journal of Australia},
  year={2007},
  volume={186 2},
  pages={91-4}
}
Over a 3-year period, seven patients who were taking HMG-CoA reductase inhibitors (statins) presented to our respiratory service with interstitial pneumonitis. Clinical course varied, with the condition responding to prednisolone treatment and cessation of statins in three patients, and progressing slowly despite this management in another three, while one… CONTINUE READING